HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials

Heart Rhythm

Volumn 11, Issue 7, 2014, Pages 1270-1303

  Kusumoto, Fred M ^a   Calkins, Hugh ^b   Boehmer, John ^c   Buxton, Alfred E ^d   Chung, Mina K ^e   Gold, Michael R ^f   Hohnloser, Stefan H ^g   Indik, Julia ^h   Lee, Richard ⁱ   Mehra, Mandeep R ^j   Menon, Venu ^e   Page, Richard L ^k   Shen, Win Kuang ^l   Slotwiner, David J ^m   Warner Stevenson, Lynne ⁿ   Varosy, Paul D ^o   Welikovitch, Lisa ^p  

^a MAYO CLINIC   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g GOETHE UNIVERSITY   (Germany)

^h UNIVERSITY OF ARIZONA   (United States)

ⁱ SAINT LOUIS UNIVERSITY   (United States)

^j HARVARD MEDICAL SCHOOL   (United States)

^k UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^l MAYO CLINIC   (United States)

^m DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

ⁿ BRIGHAM AND WOMEN S HOSPITAL   (United States)

^o VETERANS AFFAIRS MEDICAL CENTER   (United States)

^p UNIVERSITY OF CALGARY   (Canada)

more..

Author keywords

Defibrillator; Dual chamber; ICD; Myocardial infarction; Nonischemic cardiomyopathy; Revascularization

Indexed keywords

ARTICLE; CONSENSUS DEVELOPMENT; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTATION; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SUDDEN CARDIAC DEATH; ADVERSE EFFECTS; ARRHYTHMIAS, CARDIAC; CARDIOLOGY; CARDIOMYOPATHIES; CARDIOVERSION; MYOCARDIAL INFARCTION; ORGANIZATION AND MANAGEMENT; PROCEDURES; STANDARDS;

ARRHYTHMIAS, CARDIAC; CARDIOLOGY; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; HUMANS; MYOCARDIAL INFARCTION; SOCIETIES, MEDICAL;

EID: 84903155075     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.03.041     Document Type: Article

References (152)

1. G.H. Bardy, K.L. Lee, D.B. Mark for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 3 2005 225 237
2. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, D.S. Cannom, J.P. Daubert, S.L. Higgins, M.W. Brown, M.L. Andrews for the Multicenter Automatic Defibrillator Implantation Trial II Investigators Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 12 2002 877 883
3. Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias N Engl J Med 337 1997 1576 1583
4. C.W. Yancy, M. Jessup, B. Bozkurt for the ACC/AHA Task Force Members 2013 ACC/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 2013 e147 239
5. A.E. Epstein, J.P. Dimarco, K.A. Ellenbogen, N.A.M. Estes III, R.A. Freedman, L.S. Gettes, A.M. Gillinov, G. Gregoratos, S.C. Hammill, D.L. Hayes, M.A. Hlatky, L.K. Newby, R.L. Page, M.H. Schoenfeld, M.J. Silka, L.W. Stevenson, M.O. Sweeney ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons Heart Rhythm 5 6 2008 934 955
6. D.P. Zipes, A.J. Camm, M. Borggrefe, A.E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A.J. Moss, R.J. Myerburg, S.G. Priori, M.A. Quinones, D.M. Roden, M.J. Silka, C. Tracy ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society J Am Coll Cardiol 48 5 2006 e247 e346
7. P.T. O'Gara, F.G. Kushner, D.D. Ascheim, D.E. Casey Jr, M.K. Chung, J.A. de Lemos, S.M. Ettinger, J.C. Fang, F.M. Fesmire, B.A. Franklin, C.B. Granger, H.M. Krumholz, J.A. Linderbaum, D.A. Morrow, L.K. Newby, J.P. Ornato, N. Ou, M.J. Radford, J.E. Tamis-Holland, C.L. Tommaso, C.M. Tracy, Y.J. Woo, D.X. Zhao 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions J Am Coll Cardiol 61 4 2013 e78 140
8. C.M. Tracy, A.E. Epstein, D. Darbar, J.P. DiMarco, S.B. Dunbar, N.A.M. Estes 3rd, T.B. Ferguson Jr, S.C. Hammill, P.E. Karasik, M.S. Link, J.E. Marine, M.H. Schoenfeld, A.J. Shanker, M.J. Silka, L.W. Stevenson, W.G. Stevenson, and P.D. Varosy 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Heart Failure Society of America, and Society of Thoracic Surgeons Heart Rhythm 9 10 2012 1737 1753
9. A.M. Russo, R.F. Stainback, S.R. Bailey, A.E. Epstein, P.A. Heidenreich, M. Jessup, S. Kapa, M.S. Kremers, B.D. Lindsay, and L.W. Stevenson ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance Heart Rhythm 10 4 2013 e11 e58
10. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999 Dec 16;341(25):1882-90
11. A.J. Moss, W.J. Hall, D.S. Cannom, J.P. Daubert, S.L. Higgins, H. Klein, J.H. Levine, S. Saksena, A.L. Waldo, D. Wilber, M.W. Brown, and M. Heo Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators N Engl J Med 335 26 1996 1933 1940
12. J.T. Bigger Jr Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators N Engl J Med 337 22 1997 1569 1575
13. M.H. Kong, S.M. Al-Khatib, G.D. Sanders, V. Hasselblad, and E.D. Peterson Use of implantable cardioverter-defibrillators for primary prevention in older patients: a systemic literature review and meta-analysis Cardiol J 18 2011 503 514
14. S.H. Hohnloser, K.H. Kuck, P. Dorian, R.S. Roberts, J.R. Hampton, R. Hatala, E. Fain, M. Gent, S.J. Connolly for the DINAMIT Investigators Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction N Engl J Med 351 24 2004 2481 2488
15. G. Steinbeck, D. Andresen, K. Seidl for the IRIS Investigators Defibrillator implantation early after myocardial infarction N Engl J Med 361 15 2009 1427 1436
16. A. Kadish, A. Dyer, J.P. Daubert for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 21 2004 2151 2158
17. K. Thygesen, J.S. Alpert, A.S. Jaffe, M.L. Simoons, B.R. Chaitman, H.D. White the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction Third universal definition of myocardial infarction J Am Coll Cardiol 60 16 2012 1581 1598
18. L.K. Newby, R.L. Jesse, and J.D. Babb et al. ACC 2012 Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin Elevations: a Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents J Am Coll Cardiol 60 23 2012 2427 2463
19. D.P. Zipes, and H.J. Wellens Sudden cardiac death Circulation 98 1998 2334 2351
20. S.D. Solomon, S. Zelenkofske, J.J. McMurray for the Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both N Engl J Med 352 25 2005 2581 2588
21. P. Dorian, S.H. Hohnloser, K.E. Thorpe, R.S. Roberts, K.H. Kuck, M. Gent, and S.J. Connolly Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT) Circulation 122 25 2010 2645 2652
22. A.C. Pouleur, E. Barkoudah, H. Uno for the VALIANT Investigators Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both Circulation 122 6 2010 597 602
23. I. Goldenberg, A.J. Moss, W.J. Hall, S. McNitt, W. Zareba, M.L. Andrews, D.S. Cannom for the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II Investigators Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II Circulation 113 24 2006 2810 2817
24. T.J. Bunch, H.T. May, and T.L. Bair et al. Trends in early and late mortality in patients undergoing coronary catheterization for myocardial infarction: implications on observation periods and risk factors to determine ICD candidacy Heart Rhythm 8 2011 1460 1466
25. A. Volpi, A. Cavalli, L. Santoro, and E. Negri Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) database Am J Cardiol 82 3 1998 265 271
26. K.H. Newby, T. Thompson, A. Stebbins, E.J. Topol, R.M. Califf, and A. Natale Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators Circulation 98 23 1998 2567 2573
27. R.H. Mehta, A.Z. Starr, R.D. Lopes, J.S. Hochman, P. Widimsky, K.S. Pieper, P.W. Armstrong, C.B. Granger for the APEX AMI Investigators Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention JAMA 301 17 2009 1779 1789
28. R.H. Mehta, K.J. Harjai, L. Grines, G.W. Stone, J. Boura, D. Cox, W. O'Neill, and C.L. Grines Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes J Am Coll Cardiol 43 10 2004 1765 1772
29. The PURSUIT Trial Investigators Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes N Engl J Med 339 1998 436 443
30. J.P. Piccini, J.A. White, and R.H. Mehta et al. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes Circulation 126 1 2012 41 49
31. S. Ye, M. Grunnert, J.J. Thune, K.M. Stephenson, H. Uno, P.V. Finn, J.J. McMurray, E.J. Velazquez, R. Califf, M.A. Pfeffer, and S.D. Solomon Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention Circulation 123 23 2011 2674 2680
32. E.M. Aliot, W.G. Stevenson, J.M. Almendral-Garrote for the European Heart Rhythm Association (EHRA); Registered Branch of the European Society of Cardiology (ESC); Heart Rhythm Society (HRS); American College of Cardiology (ACC); American Heart Association (AHA) EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA) Heart Rhythm 6 6 2009 886 933
33. S.J. Connolly, M. Gent, R.S. Roberts, P. Dorian, D. Roy, R.S. Sheldon, L.B. Mitchell, M.S. Green, G.J. Klein, and B. O'Brien Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone Circulation 101 11 2000 1297 1302
34. S. Kumar, G. Sivagangaban, S. Zaman, E.B. West, A. Narayan, A. Thiagalingam, and P. Kovoor Electrophysiology-guided defibrillator implantation early after ST-elevation myocardial infarction Heart Rhythm 7 2010 1589 1597
35. G.H. Van Welsenes, J.B. Van Rees, J. Thijssen, S.A. Trines, L. Van Erven, M.J. Schalij, and C.J. Borleffs Primary prevention implantable cardioverter defibrillator recipients: the need for defibrillator back-up after an event-free first battery service-life J Cardiovasc Electrophysiol 22 12 2011 1346 1350
36. M.R. Da Rosa, J.L. Sapp, J.G. Howlett, A. Falkenham, and J.F. Légaré Implantable cardioverter-defibrillator implantation as a bridge to cardiac transplantation J Heart Lung Transplant 26 12 2007 1336 1339
37. S.E. Sandner, G. Wieselthaler, A. Zuckermann, S. Taghavi, H. Schmidinger, R. Pacher, M. Ploner, G. Laufer, E. Wolner, and M. Grimm Survival benefit of the implantable cardioverter-defibrillator in patients on the waiting list for cardiac transplantation Circulation 104 12 Suppl 1 2001 I171 I176
38. C. Ermis, G. Zadeii, A.X. Zhu, W. Fabian, J. Collins, K.G. Lurie, S. Sakaguchi, and D.G. Benditt Improved survival of cardiac transplantation candidates with implantable cardioverter defibrillator therapy: role of beta-blocker or amiodarone treatment J Cardiovasc Electrophysiol 14 2003 578 583
39. M.O. Sweeney, J.N. Ruskin, H. Garan, B.A. McGovern, M.L. Guy, D.F. Torchiana, G.J. Vlahakes, J.B. Newell, M.J. Semigran, and G.W. Dec Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation Circulation 92 1995 3273 3281
40. A.R. Garan, M. Yuzefpolskaya, P.C. Colombo, J.P. Morrow, R. Te-Frey, D. Dano, H. Takayama, Y. Naka, H. Garan, U.P. Jorde, and N. Uriel Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention? J Am Coll Cardiol 61 25 2013 2542 2550
41. A.D. Enriquez, B. Calenda, M.A. Miller, A.C. Anyanwu, and S.P. Pinney The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices Circ Arrhythm Electrophysiol 6 4 2013 668 674
42. M.K. Chung, S.J. Szymkiewicz, M. Shao, E. Zishiri, M.J. Niebauer, B.D. Lindsay, and P.J. Tchou Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival J Am Coll Cardiol 56 3 2010 194 203
43. L.A. Pires, G.E. Hafley, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prystowsky, and A.E. Buxton for the Multicenter Unsustained Tachycardia Trial Investigators. Prognostic significance of nonsustained ventricular tachycardia identified postoperatively after coronary artery bypass surgery in patients with left ventricular dysfunction J Cardiovasc Electrophysiol 13 8 2002 757 763
44. A. Barsheshet, I. Goldenberg, C.R. Narins, A.J. Moss, S. McNitt, P.J. Wang, D.T. Huang, W.J. Hall, W. Zareba, M. Eldar, and V. Guetta Time dependence of life-threatening ventricular tachyarrhythmias after coronary revascularization in MADIT-CRT Heart Rhythm 7 2010 1421 1427
45. I. Goldenberg, A.J. Moss, S. McNitt, W. Zareba, W.J. Hall, M.L. Andrews, D.J. Wilber, and H.U. Klein Time dependence of defibrillator benefit after coronary revascularization in the multicenter automatic defibrillator implantation trial (MADIT)-II J Am Coll Cardiol 47 2006 1811 1817
46. A. Barsheshet, I. Goldenberg, A.J. Moss, D.T. Huang, W. Zareba, S. McNitt, H.U. Klein, and V. Guetta Effect of elapsed time from coronary revascularization to implantation of a cardioverter defibrillator on long-term survival in the MADIT-II trial J Cardiovasc Electrophysiol 22 2011 1237 1242
47. S.M. Al-Khatib, A.S. Hellkamp, K.L. Lee, J. Anderson, J.E. Poole, D.B. Mark, and G.H. Bardy Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the sudden cardiac death in heart failure trial (SCD-HeFT) J Cardiovasc Electrophysiol 19 2008 1059 1065
48. A.S. Al-Dadah, R.K. Voeller, P. Rahgozar, J.S. Lawton, M.R. Moon, M.K. Pasque, R.J. Damiano Jr, and N. Moazami Implantable cardioverter-defibrillators improve survival after coronary artery bypass grafting in patients with severely impaired left ventricular function J Cardiothorac Surg 2 2007 6
49. J.T. Bigger Jr, W. Whang, J.N. Rottman, R.E. Kleiger, C.D. Gottlieb, P.B. Namerow, R.C. Steinman, and N.A. Estes 3rd Mechanisms of death in the CABG Patch trial: a randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery Circulation 99 1999 1416 1421
50. F. Jung, J.M. Herre, M.A. Wood, S. O'Donoghue, D.S. Cannom, J.R. Windle, T. Hilbel, D.R. Talreja, M.F. Parides, J.T. Bigger Jr, J.P. DiMarco for the CABG Patch Investigators Influence of wall motion score on mortality after coronary artery bypass surgery in the CABG-patch trial Int J Cardiol 82 2002 41 47
51. M. Gheorghiade, J.D. Flaherty, G.C. Fonarow, R.V. Desai, R. Lee, D. McGiffin, T.E. Love, I. Aban, E.J. Eichhorn, R.O. Bonow, and A. Ahmed Coronary artery disease, coronary revascularization, and outcomes in chronic advanced systolic heart failure Int J Cardiol 151 2011 69 75
52. W.S. Weintraub, M.V. Grau-Sepulveda, and J.M. Weiss et al. Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the national cardiovascular data registry Circulation 125 2012 1501 1510
53. D.M. Shahian, S.M. O'Brien, and S. Sheng et al. Predictors of long-term survival after coronary artery bypass grafting surgery: results from the society of thoracic surgeons adult cardiac surgery database (the ASCERT study) Circulation 125 2012 1491 1500
54. M.F. Nageh, J.J. Kim, J. Chung, and J.F. Yao The role of implantable cardioverter defibrillators in high-risk CABG patients identified early post-cardiac surgery Europace 13 2011 70 76
55. S. Mittal, D.J. Lomnitz, S. Mirchandani, K.M. Stein, S.M. Markowitz, D.J. Slotwiner, S. Iwai, M.K. Das, and B.B. Lerman Prognostic significance of nonsustained ventricular tachycardia after revascularization J Cardiovasc Electrophysiol 13 2002 342 346
56. I. Bolad, C. MacLellan, S. Karanam, F. Parrella, G. Michaud, R. D'Agostino, D. Shahian, R. John, and D. Martin Effectiveness of early implantation of cardioverter defibrillator for postoperative ventricular tachyarrhythmia Am J Cardiol 94 2004 376 378
57. J.M. John, A. Hussein, N. Imran, S.J. Durham, B.P. Grubb, and Y. Kanjwal Underutilization of implantable cardioverter defibrillators post coronary artery bypass grafting in patients with systolic dysfunction Pacing Clin Electrophysiol 33 2010 727 733
58. E.T. Zishiri, S. Williams, E.M. Cronin, E.H. Blackstone, S.G. Ellis, E.E. Roselli, N.G. Smedira, A.M. Gillinov, J.A. Glad, P.J. Tchou, S.J. Szymkiewicz, and M.K. Chung Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator Circ Arrhythm Electrophysiol 6 1 2013 117 128
59. V. Rizzello, D. Poldermans, E. Biagini, A.F. Schinkel, E. Boersma, A. Boccanelli, T. Marwick, J.R. Roelandt, and J.J. Bax Prognosis of patients with ischaemic cardiomyopathy after coronary revascularization: relation to viability and improvement in left ventricular ejection fraction Heart 95 2009 1273 1277
60. K.C. Allman, L.J. Shaw, R. Hachamovitch, and J.E. Udelson Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis J Am Coll Cardiol 39 2002 1151 1158
61. K. Chatterjee Is detection of hibernating myocardium necessary in deciding revascularization in systolic heart failure? Am J Cardiol 106 2010 236 242
62. R.O. Bonow, G. Maurer, and K.L. Lee et al. Myocardial viability and survival in ischemic left ventricular dysfunction N Engl J Med 364 2011 1617 1625
63. J. Alexandre, E. Saloux, A.E. Dugue, A. Lebon, A. Lemaitre, V. Roule, F. Labombarda, N. Provost, S. Gomes, P. Scanu, and P. Milliez Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease J Cardiovasc Magn Reson 15 2013 12
64. S.D. Roes, C.J. Borleffs, R.J. van der Geest, J.J. Westenberg, N.A. Marsan, T.A. Kaandorp, J.H. Reiber, K. Zeppenfeld, H.J. Lamb, A. de Roos, M.J. Schalij, and J.J. Bax Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator Circ Cardiovasc Imaging 2 2009 183 190
65. S. de Haan, T.A. Meijers, P. Knaapen, A.M. Beek, A.C. van Rossum, and C.P. Allaart Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: comparison of previously validated models Heart 97 2011 1951 1956
66. P. Gao, R. Yee, and L. Gula et al. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging Circ Cardiovasc Imaging 5 2012 448 456
67. P.A. Scott, J.M. Morgan, N. Carroll, D.C. Murday, P.R. Roberts, C.R. Peebles, S.P. Harden, and N.P. Curzen The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators Circ Arrhythm Electrophysiol 4 2011 324 330
68. D.G. Wyse, P.L. Friedman, M.A. Brodsky, K.J. Beckman, M.D. Carlson, A.B. Curtis, A.P. Hallstrom, M.H. Raitt, B.L. Wilkoff, H.L. Greene for the AVID Investigators Life-threatening ventricular arrhythmias due to transient or correctable causes: high risk for death in follow-up J Am Coll Cardiol 38 2001 1718 1724
69. J.R. Cook, C. Rizo-Patron, A.B. Curtis, A.M. Gillis, J.T. Bigger, S.P. Kutalek, J. Coromilas, B.I. Hofer, J. Powell, A.P. Hallstrom for the AVID Investigators Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) registry Am Heart J 143 2002 821 826
70. D.L. Ngaage, A.R. Cale, M.E. Cowen, S. Griffin, and L. Guvendik Early and late survival after surgical revascularization for ischemic ventricular fibrillation/tachycardia Ann Thorac Surg 85 2008 1278 1281
71. E.G. Daoud, M. Niebauer, W.H. Kou, K.C. Man, L. Horwood, F. Morady, and S.A. Strickberger Incidence of implantable defibrillator discharges after coronary revascularization in survivors of ischemic sudden cardiac death Am Heart J 130 1995 277 280
72. E.A. Telfer, A. Mecca, M. Martini, and B. Olshansky Implantable defibrillator use for de novo ventricular tachyarrhythmias encountered after cardiac surgery Pacing Clin Electrophysiol 25 2002 951 956
73. A. Natale, J. Sra, K. Axtell, C. Maglio, A. Dhala, Z. Blanck, S. Deshpande, M. Jazayeri, and M. Akhtar Ventricular fibrillation and polymorphic ventricular tachycardia with critical coronary artery stenosis: does bypass surgery suffice? J Cardiovasc Electrophysiol 5 12 1994 988 994
74. P. Kelly, J.N. Ruskin, G.J. Vlahakes, M.J. Buckley Jr, C.S. Freeman, and H. Garan Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival J Am Coll Cardiol 15 2 1990 267 273
75. O. Merin, M. Ilan, A. Oren, D. Fink, M. Deeb, D. Bitran, and S. Silberman Permanent pacemaker implantation following cardiac surgery: indications and long-term follow-up Pacing Clin Electrophysiol 32 2009 7 12
76. B.S. Goldman, T.J. Hill, R.D. Weisel, H.E. Scully, L.L. Mickleborough, J. Pym, and R.J. Baird Permanent cardiac pacing after open-heart surgery: acquired heart disease Pacing Clin Electrophysiol 7 1984 367 371
77. Y. Ashida, S. Ohgi, H. Kuroda, S. Ishiguro, T. Hamasaki, S. Miyasaka, and K. Ono Permanent cardiac pacing following surgery for acquired valvular disease Ann Thorac Cardiovasc Surg 6 2000 161 166
78. R. Zakhia Doueihi, M.F. Leloux, L. De Roy, and R. Kremer Permanent cardiac pacing for prolonged second and third degree atrioventricular block complicating cardiac valve replacement Acta Cardiol 47 1992 157 166
79. B.A. Koplan, W.G. Stevenson, L.M. Epstein, S.F. Aranki, and W.H. Maisel Development and validation of a simple risk score to predict the need for permanent pacing after cardiac valve surgery J Am Coll Cardiol 41 2003 795 801
80. W.T. Abraham, W.G. Fisher, and A.L. Smith et al. Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
81. S. Cazeau, C. Leclercq, T. Lavergne, S. Walker, C. Varma, C. Linde, S. Garrigue, L. Kappenberger, G.A. Haywood, M. Santini, C. Bailleul, and J.C. Daubert Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay N Engl J Med 344 2001 873 880
82. M.R. Bristow, L.A. Saxon, J. Boehmer, S. Krueger, D.A. Kass, T. De Marco, P. Carson, L. DiCarlo, D. DeMets, B.G. White, D.W. DeVries, A.M. Feldman for the COMPANION Investigators Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
83. J.G.F. Cleland, J. Daubert, E. Erdmann for the CARE-HF Investigators The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
84. A.J. Moss, W.J. Hall, and D.S. Cannom et al. Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
85. A.S.L. Tang, G.A. Wells, and M. Talajic et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
86. J.E. Poole, M.J. Gleva, and T. Mela et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the replace registry Circulation 122 2010 1553 1561
87. A.M. Gillis, A.M. Russo, K.A. Ellenbogen, C.D. Swerdlow, B. Olshansky, S.M. Al-Khatib, J.F. Beshai, J.M. McComb, J.C. Nielsen, J.M. Philpott, W.K. Shen for the Heart Rhythm Society; American College of Cardiology Foundation HRS/ACC expert consensus statement on pacemaker device and mode selection Developed in partnership between the Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACC) and in collaboration with the Society of Thoracic Surgeons Heart Rhythm 9 8 2012 1344 1365
88. K.H. Kuck, R. Cappato, J. Siebels, and R. Ruppel Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH) Circulation 102 2000 748 754
89. J.N. Catanzaro, A.N. Makaryus, C. Sison, C. Vavasis, D. Donaldson, S. Beldner, B. Boal, and R. Jadonath Clinical predictors of appropriate implantable-cardioverter defibrillator discharge Pacing Clin Electrophysiol 30 Suppl 1 2007 S120 S124
90. D.J. Cantillon, K.G. Tarakji, D.J. Kumbhani, N.G. Smedira, R.C. Starling, and B.L. Wilkoff Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator Heart Rhythm 7 2010 466 471
91. M.M. Refaat, T. Tanaka, R.L. Kormos, D. McNamara, J. Teuteberg, S. Winowich, B. London, and M.A. Simon Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients J Card Fail 18 2012 140 145
92. O. Ziv, J. Dizon, A. Thosani, Y. Naka, A.R. Magnano, and H. Garan Effects of left ventricular assist device therapy on ventricular arrhythmias J Am Coll Cardiol 45 2005 1428 1434
93. M. Refaat, E. Chemaly, D. Lebeche, J.K. Gwathmey, and R.J. Hajjar Ventricular arrhythmias after left ventricular assist device implantation Pacing Clin Electrophysiol 31 2008 1246 1252
94. W.G. Stevenson, L.W. Stevenson, H.R. Middlekauff, and L.A. Saxon Sudden death prevention in patients with advanced ventricular dysfunction Circulation 88 1993 2953 2961
95. D.M. McNamara, R.C. Starling, L.T. Cooper, J.P. Boehmer, P.J. Mather, K.M. Janosko, J. Gorcsan 3rd, K.E. Kip, G.W. Dec for the IMAC Investigators Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study J Am Coll Cardiol 58 11 2011 1112 1118
96. W. Grimm, M. Christ, J. Bach, H.H. Müller, and B. Maisch Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study Circulation 108 23 2003 2883 2891
97. W. Grimm, M. Christ, and B. Maisch Long runs of non-sustained ventricular tachycardia on 24-hour ambulatory electrocardiogram predict major arrhythmic events in patients with idiopathic dilated cardiomyopathy Pacing Clin Electrophysiol 28 Suppl 1 2005 S207 S210
98. D. Bänsch, M. Antz, S. Boczor, M. Volkmer, J. Tebbenjohanns, K. Seidl, M. Block, F. Gietzen, J. Berger, and K.H. Kuck Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT) Circulation 105 12 2002 1453 1458
99. S.A. Strickberger, J.D. Hummel, T.G. Bartlett, H.I. Frumin, C.D. Schuger, S.L. Beau, C. Bitar, F. Morady for the AMIOVIRT Investigators Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIRT J Am Coll Cardiol 41 10 2003 1707 1712
100. A. Kadish, A. Schaechter, H. Subacius, E. Thattassery, W. Sanders, K.P. Anderson, A. Dyer, J. Goldberger, and J. Levine Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators J Am Coll Cardiol 47 12 2006 2477 2482
101. K.J. Makati, A.E. Fish, H.H. England, H. Tighiouart, N.A. Estes 3rd, and M.S. Link Equivalent arrhythmic risk in patients recently diagnosed with dilated cardiomyopathy compared with patients diagnosed for 9 months or more Heart Rhythm 3 4 2006 397 403
102. R. Sheppard, P.J. Mather, J.D. Alexis, R.C. Starling, J.P. Boehmer, V. Thohan, D.F. Pauly, D.W. Markham, M. Zucker, K.E. Kip, D.M. McNamara for the IMAC Investigators Implantable cardiac defibrillators and sudden death in recent onset nonischemic cardiomyopathy: results from IMAC2 J Card Fail 18 9 2012 675 681
103. M. Zecchin, M. Merlo, A. Pivetta, G. Barbati, C. Lutman, D. Gregori, L.V. Serdoz, S. Bardari, S. Magnani, A. Di Lenarda, A. Proclemer, and G. Sinagra How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?" Am J Cardiol 109 5 2012 729 735
104. J.E. Schliamser, A.H. Kadish, H. Subacius, A. Shalaby, A. Schaechter, J. Levine, J.J. Goldberger for the DEFINITE Investigators Significance of Follow-Up Left Ventricular Ejection Fraction Measurements in the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Trial Heart Rhythm 10 2013 838 846
105. A. Gulati, A. Jabbour, and T.F. Ismail et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy JAMA 309 9 2013 896 908
106. M.J. Ackerman, S.G. Priori, and S. Willems et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) Heart Rhythm 8 8 2011 1308 1339
107. W.J. Groh Arrhythmias in the muscular dystrophies Heart Rhythm 9 11 2012 1890 1895
108. D. Bhakta, C. Shen, J. Kron, A.E. Epstein, R.M. Pascuzzi, and W.J. Groh Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population J Cardiovasc Electrophysiol 22 12 2011 1369 1375
109. C. Meune, J.H. Van Berlo, F. Anselme, G. Bonne, Y.M. Pinto, and D. Duboc Primary prevention of sudden death in patients with lamin A/C gene mutations N Engl J Med 354 2 2006 209 210
110. K.M. Brauch, M.L. Karst, K.J. Herron, M. de Andrade, P.A. Pellikka, R.J. Rodeheffer, V.V. Michels, and T.M. Olson Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy J Am Coll Cardiol 54 10 2009 930 941
111. C.Z. Chiu, S. Nakatani, and G. Zhang et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis Am J Cardiol 95 2005 143 146
112. Y. Yazaki, M. Isobe, and S. Hiramitsu et al. Comparison of clinical features and prognosis of cardiac sarcoidosis and idiopathic dilated cardiomyopathy Am J Cardiol 82 1998 537 540
113. I.A. Van Rijsingen, E. Arbustini, and P.M. Elliott et al. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers: a European cohort study J Am Coll Cardiol 59 5 2012 493 500
114. R. Kandolin, J. Lehtonen, and M. Kupari Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults Circ Arrhythm Electrophysiol 4 2011 303 309
115. C. Meyer, P. Schueller, A. Rodenbeck, M. Hennersdorf, M. Merx, J. Winter, T. Rassaf, M. Kelm, and P. Schauerte Primary and secondary prevention of ventricular arrhythmias in dilated cardiomyopathy: nonsustained, sustained, and incessant Int Heart J 50 6 2009 741 751
116. H.R. Middlekauff, W.G. Stevenson, L.W. Stevenson, and L.A. Saxon Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope J Am Coll Cardiol 21 1993 110 116
117. R.S. Phang, D. Kang, H. Tighiourt, N.A.M. Estes, and M.S. Link High Risk of ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy presenting with syncope Am J Cardiol 97 2006 416 420
118. H. Raasch, B.C. Jensen, P.P. Chang, J.P. Mounsey, A.K. Gehi, E.H. Chung, B.C. Sheridan, A. Bowen, and J.N. Katz Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation Am Heart J 164 3 2012 373 378
119. J.P. Boehmer, R.C. Starling, L.T. Cooper, G. Torre-Amione, I. Wittstein, G.W. Dec, D.W. Markham, M.J. Zucker, J. Gorcsan 3rd, C. McTiernan, K. Kip, and D.M. McNamara IMAC Investigators. Left ventricular assist device support and myocardial recovery in recent onset cardiomyopathy J Card Fail 18 2012 755 761
120. G. Gregoratos, J. Abrams, A.E. Epstein, R.A. Freedman, D.L. Hayes, M.A. Hlatky, R.E. Kerber, G.V. Naccarelli, M.H. Schoenfeld, M.J. Silka, and S.L. Winters ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) Circulation 106 2002 2145 2161
121. D.D. Matlock, P.N. Peterson, Y. Wang, J.P. Curtis, M.R. Reynolds, P.D. Varosy, and F.A. Masoudi Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry Arch Intern Med 172 2012 634 641 (discussion 641)
122. L.D. Berenbom, B.C. Weiford, J.L. Vacek, M.P. Emert, W.J. Hall, M.L. Andrews, S. McNitt, W. Zareba, and A.J. Moss Differences in outcomes between patients treated with single- versus dual-chamber implantable cardioverter defibrillators: a substudy of the Multicenter Automatic Defibrillator Implantation Trial II Ann Noninvas Electrocardiol 10 2005 429 435
123. T.A. Dewland, C.N. Pellegrini, Y. Wang, G.M. Marcus, E. Keung, and P.D. Varosy Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry J Am Coll Cardiol 58 2011 1007 1013
124. J. Almendral, F. Arribas, C. Wolpert, R. Ricci, P. Adragao, E. Cobo, X. Navarro, A. Quesada, D.S. Committee, D.W. Committee for DATAS Investigators Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual-chamber and Atrial Tachyarrhythmias Adverse Events Study) trial Europace 10 2008 528 535
125. P. Dorian, F. Philippon, B. Thibault, S. Kimber, L. Sterns, M. Greene, D. Newman, R. Gelaznikas, A. Barr for ASTRID Investigators Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator Heart Rhythm 1 2004 540 547
126. I. Deisenhofer, C. Kolb, G. Ndrepepa, J. Schreieck, M. Karch, S. Schmieder, B. Zrenner, and C. Schmitt Do current dual-chamber cardioverter defibrillators have advantages over conventional single-chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study J Cardiovasc Electrophysiol 12 2001 134 142
127. P.A. Friedman, R.L. McClelland, and W.R. Bamlet et al. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study Circulation 113 2006 2871 2879
128. D.A. Theuns, A.P. Klootwijk, D.M. Goedhart, and L.J. Jordaens Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms J Am Coll Cardiol 44 2004 2362 2367
129. Z. Goldberger, B. Elbel, C.A. McPherson, A.D. Paltiel, and R. Lampert Cost advantage of dual-chamber versus single-chamber cardioverter-defibrillator implantation J Am Coll Cardiol 46 2005 850 857
130. D.S. Lee, A.D. Krahn, J.S. Healey for the Investigators of the Ontario ICDD Evaluation of early complications related to de novo cardioverter defibrillator implantation insights from the Ontario ICD database J Am Coll Cardiol 55 2010 774 782
131. A. Cheng, Y. Wang, J.P. Curtis, and P.D. Varosy Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry J Am Coll Cardiol 56 2010 1651 1656
132. B.L. Wilkoff, J.R. Cook, A.E. Epstein, H.L. Greene, A.P. Hallstrom, H. Hsia, S.P. Kutalek, A. Sharma, C. Dual for the Investigators VVIIDT Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual-chamber and VVI Implantable Defibrillator (DAVID) trial JAMA 288 2002 3115 3123
133. S.P. Kutalek, A.D. Sharma, M.J. McWilliams, B.L. Wilkoff, A. Leonen, A.P. Hallstrom, P.J. Kudenchuk for the DAVID Investigators Effect of pacing for soft indications on mortality and heart failure in the Dual-chamber and VVI Implantable Defibrillator (DAVID) trial Pacing Clin Electrophysiol 31 7 2008 828 837
134. B. Olshansky, J.D. Day, S. Moore, L. Gering, M. Rosenbaum, M. McGuire, S. Brown, and D.R. Lerew Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) study Circulation 115 2007 9 16
135. B.L. Wilkoff, B.D. Williamson, R.S. Stern, S.L. Moore, F. Lu, S.W. Lee, U.M. Birgersdotter-Green, M.S. Wathen, I.C. Van Gelder, B.M. Heubner, M.L. Brown, K.K. Holloman for the PREPARE Study Investigators Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study J Am Coll Cardiol 52 2008 541 550
136. M.R. Gold, D.A. Theuns, B.P. Knight, J.L. Sturdivant, R. Sanghera, K.A. Ellenbogen, M.A. Wood, and M.C. Burke Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study J Cardiovasc Electrophysiol 23 2012 359 366
137. A.J. Moss, C. Schuger, C.A. Beck for the MADIT-RIT Trial Investigators Reduction in inappropriate therapy and mortality through ICD programming N Engl J Med 367 2012 2275 2283
138. M. Gasparini, A. Proclemer, C. Klersy, A. Kloppe, M. Lunati, J.B. Ferrer, A. Hersi, M. Gulaj, M.C. Wijfels, E. Santi, L. Manotta, and A. Arenal Effect of long-detection interval vs. standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial JAMA 309 18 2013 1903 1911
139. M.O. Sweeney, M.S. Wathen, K. Volosin, I. Abdalla, P.J. DeGroot, M.F. Otterness, and A.J. Stark Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: Results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial Circulation 111 2005 2898 2905
140. P.A. Friedman, J. Slusser, D. Hodge, D. Bradley, C. Koestler, F. Kusumoto, T.M. Munger, K. Bailey, A. Militanu, and M. Glikson Prospective randomized trial of dual-chamber vs. Single-chamber ICDs to minimize shocks in optimally programmed devices Heart Rhythm 2012 (Late-Breaking Clinical Trial. Lecture conducted at Heart Rhythm Society 33rd Annual Scientific Sessions, Boston Massachusetts)
141. Beta-Blocker Heart Attack Trial Research Group A randomized trial of propranolol in patients with acute myocardial infarction: II. Morbidity results JAMA 250 1983 2814 2819
142. The Capricorn Investigators Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 2001 1385 1390
143. B.J. Gersh, B.J. Maron, R.O. Bonow, J.A. Dearani, M.A. Fifer, M.S. Link, S.S. Naidu, R.A. Nishimura, S.R. Ommen, H. Rakowski, C.E. Seidman, J.A. Towbin, J.E. Udelson, C.W. Yancy 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J Am Coll Cardiol 58 25 2011 e212 e260
144. J.S. Steinberg, and S. Mittal The federal audit of implantable cardioverter-defibrillator implants: lessons learned J Am Coll Cardiol 59 14 2012 1270 1274
145. M.S. Kremers, S.C. Hammill, and C.I. Berul et al. The National ICD Registry Report: Version 2.1 including leads and pediatrics for years 2010 and 2011 Heart Rhythm 10 4 2013 e59 e65
146. S.M. Al-Khatib, A. Hellkamp, J. Curtis, D. Mark, E. Peterson, G.D. Sanders, P.A. Heidenreich, A.F. Hernandez, L.H. Curtis, and S. Hammill Non-evidence-based ICD implantations in the United States JAMA 305 1 2011 43 49
147. S.M. Al-Khatib, A. Hellkamp, and G.H. Bardy et al. Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs. clinical trials JAMA 309 1 2013 55 62
148. C.P. Cannon, R.G. Brindis, B.R. Chaitman, D.J. Cohen, J.T. Cross Jr, J.P. Drozda Jr, F.M. Fesmire, D.J. Fintel, G.C. Fonarow, K.A. Fox, D.T. Gray, R.A. Harrington, K.A. Hicks, J.E. Hollander, H. Krumholz, D.R. Labarthe, J.B. Long, A.M. Mascette, C. Meyer, E.D. Peterson, M.J. Radford, M.T. Roe, J.B. Richmann, H.P. Selker, D.M. Shahian, R.E. Shaw, S. Sprenger, R. Swor, J.A. Underberg, F. Van de Werf, B.H. Weiner, and W.S. Weintraub 2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards). Developed in collaboration with American College of Emergency Physicians, Emergency Nurses Association, National Association of Emergency Medical Technicians, National Association of EMS Physicians, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Patient Care, and Society of Thoracic Surgeons J Am Coll Cardiol 61 9 2013 992 1025
149. J.M. Castellanos, L.M. Smith, P.D. Varosy, C. Dehlendorf, and G.M. Marcus Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: a national survey Heart Rhythm 9 6 2012 874 881
150. M.R. Mehra, C.W. Yancy, N.M. Albert, A.B. Curtis, W.G. Stough, M. Gheorghiade, J.T. Heywood, M.L. McBride, C.M. O'Connor, D. Reynolds, M.N. Walsh, and G.C. Fonarow Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: findings from IMPROVE HF Heart Rhythm 6 12 2009 1727 1734
151. M.R. Mehra, N.M. Albert, A.B. Curtis, M. Gheorghiade, J.T. Heywood, Y. Liu, C.M. O'Connor, D. Reynolds, M.N. Walsh, C.W. Yancy, and G.C. Fonarow Factors associated with improvement in guideline-based use of ICDs in eligible heart failure patients Pacing Clin Electrophysiol 35 2 2012 135 145
152. R.K. Sung, B.M. Massie, P.D. Varosy, H. Moore, J. Rumsfeld, B.K. Lee, and E. Keung Long-term electrical survival analysis of Riata and Riata ST silicone leads: National Veterans Affairs experience Heart Rhythm 9 12 2012 1954 1961